Skip to main content
MENU

Salivary Duct Carcinoma: Symptoms, Treatment, and Follow-Up

Quick answer: Salivary duct carcinoma is a rare, aggressive cancer that usually develops in the parotid gland.

Important: This information is intended for general education only and should not replace medical advice. Anyone with a parotid mass should consult an otolaryngologist, head and neck surgeon, or other qualified healthcare professional for diagnosis and treatment recommendations.

Salivary Duct Carcinoma: Quick Facts for Patients

  • Aggressive cancer: These tumors can grow quickly and invade surrounding tissues.
  • Usually in the parotid gland: Rare cases are also reported in the submandibular gland.
  • Warning signs matter: A growing or painful mass in the parotid gland, facial weakness, or neck lumps need prompt attention.
  • Specialist care is important: Patients with this diagnosis should seek care at a large hospital with advanced technology and specialists offering complex surgery and other advanced treatments.
  • Checkups after treatment: Clinical exams and scans depend on what is found during surgery.

What Is Salivary Duct Carcinoma?

Salivary duct carcinoma is a very aggressive, high-grade glandular cancer that starts in the lining of the salivary gland ducts. These tumors are usually found in the parotid gland, with a few rare cases reported in the submandibular gland.

Salivary Duct Carcinoma Characteristics

Salivary duct carcinomas can occur anywhere in the parotid gland. They are characterized by rapid growth, extreme aggressiveness, invasion of surrounding tissues and the facial nerve, and widespread metastasis.

Is Salivary Duct Carcinoma Hereditary?

No hereditary or familial findings have been reported with this tumor.

Can It Develop from a Pleomorphic Adenoma?

An untreated benign pleomorphic adenoma of the parotid gland can become malignant, which occurs in about 15% of cases, resulting in carcinoma ex pleomorphic adenoma. This malignancy can present as salivary duct carcinoma. Other cases in which a benign pleomorphic adenoma was found alongside salivary duct carcinoma suggest a possible relationship.

Is There a Known Cause?

There is no known cause of these tumors, apart from their relationship to malignant transformation of a pleomorphic adenoma.

Salivary Duct Carcinoma Symptoms and Warning Signs

These tumors are more common in men, generally in their 60s and 70s. Anyone who notices a rapid change in a long-standing parotid mass should be seen at once. Because these tumors are very aggressive, patients often experience pain, facial weakness, or one or more neck lumps.

Patients should be seen at once if they have a parotid mass that is growing, painful, or accompanied by facial nerve weakness. They may also notice neck lumps or additional parotid masses.

Why Specialist Care Is Important

Because these tumors are rare, extremely aggressive, and often fatal, patients with a confirmed or suspected diagnosis should seek care at a medical facility with advanced technology, specialists offering complex surgery, and other advanced treatments. 

Treatment will involve a major operation and additional therapy, including radiation and possibly chemotherapy.

How Salivary Duct Carcinoma Is Diagnosed?

Diagnosis requires an accurate review by an experienced pathologist. These high-grade tumors closely resemble ductal breast cancer, and metastatic breast cancer must always be ruled out using estrogen staining. Doctors may also use the names cribriform salivary carcinoma of excretory ducts and infiltrating salivary duct carcinoma to tell this cancer apart from other salivary gland cancers. 

Biomarkers Associated with a Salivary Duct Carcinoma Diagnosis
Lab tests use special stains to identify tumor cells. This specific tumor always tests positive for a protein called epithelial membrane antigen (EMA).

Salivary Duct Carcinoma Treatment: Surgery and Recovery

These tumors are extremely aggressive and are among the salivary gland cancers most likely to metastasize, spreading to parotid and neck lymph nodes, as well as distant sites.

The treatment always begins with complete imaging to assess local, regional, and distant disease. This includes a PET scan, and a CT scan or MRI of the parotid gland and neck. 

Whenever pathological examination confirms that a parotid mass is salivary duct carcinoma, a complete parotidectomy and neck dissection should always be performed.

Cancer Stage and Treatment Planning

Because these tumors are extremely aggressive, their cancer stage is almost always advanced. In most cases, there is extensive local spread beyond the parotid gland or invasion of the facial nerve. Spread to regional nodes occurs in over 70% of cases.

Salivary duct carcinoma is one of the most serious and aggressive malignancies found in the parotid gland. It metastasizes to regional nodes in over 70% of cases, often affecting multiple nodes. It spreads to distant sites in over 60% of cases, usually involving the lungs, bones, and brain.

Surgery, Radiation, and Additional Therapy

All patients with this cancer must undergo major surgery followed by radiation therapy. Decisions about chemotherapy or immunotherapy are made after reviewing surgical and imaging findings and consulting an oncologist.

What About Treatment Side Effects?

Treatment side effects depend entirely on the necessary extent of surgery and will vary for each patient.

Salivary Duct Carcinoma Prognosis and Follow-Up Care

The patients with the best outcomes have been those with small tumors measuring less than 3 cm. The absence of local invasion or metastasis is always a great finding. However, most patients, approximately 70–80%, will die of their disease, with a mean survival of 3 years after diagnosis.

Follow-Up Examinations and Imaging

Follow-up after treatment depends on the surgical findings but generally includes a clinical examination every 3 months, and imaging studies for new symptoms or at least every 6 months.

Can the Cancer Come Back?

Local recurrence after adequate initial treatment occurs in about 20% of cases. Distant metastasis has occurred in over 60% of patients.

When Should Patients Contact Their Surgeon?

After treatment, patients should always contact their surgeon about any new head or neck masses, pain, or other new findings anywhere in the body.

Treatment if the Cancer Returns

If the cancer recurs, further treatment depends entirely on a comprehensive assessment of the patient and whether the recurrence is local (in one area) or systemic (in multiple areas). Options include further surgery, chemotherapy, immunotherapy, or supportive care.

Research and Additional Treatment Options

Because this cancer is rare, accounting for about 6% of all salivary malignancies, new advances are likely to come from trials involving other, more common high-grade cancers.

Artificial Intelligence (AI) and Treatment Research

There are currently no known AI sources for new treatments or early identification of these rare but highly fatal cancers.

When are targeted therapies, immunotherapy, or clinical trials considered?

Systemic treatment is given when these cancers have spread to multiple sites and is sometimes used as an initial trial because of their behavior.

Key Takeaways About Salivary Duct Carcinoma

  • Salivary duct carcinoma is a rare, aggressive cancer that usually occurs in the parotid gland.
  • A rapidly changing mass, pain, facial weakness, or neck lumps should be evaluated promptly.
  • Specialist care and an experienced pathology review is recommended.
  • Surgery and radiation are described as central parts of treatment, with additional therapy discussed with an oncologist.
  • Regular follow-up and reporting new masses, pain, or other findings are important after treatment.
Medical Review and Source Attribution for Salivary Duct Carcinoma Guide

This educational information was provided by Kerry D. Olsen, MD, an emeritus consultant and former chair of the Division of Head and Neck Surgery within the Department of Otolaryngology–Head and Neck Surgery at Mayo Clinic in Minnesota, and an emeritus professor of otolaryngology at Mayo Clinic College of Medicine and Science.1

Reference

1. Mayo Clinic. Kerry D. Olsen, M.D. Accessed November 3, 2026. https://www.mayoclinic.org/biographies/olsen-kerry-d-m-d/bio-20054537

Medical Disclaimer

This information is intended for general education only and should not replace medical advice. Anyone with a parotid mass should speak with an otolaryngologist, head and neck surgeon, or other qualified healthcare professional for diagnosis and treatment recommendations.